Abstract
Forty-eight patients (49 eyes) had nonperforating traumatic hyphema. Twenty-eight patients (28 eyes with hyphema) received oral aminocaproic acid, an antifibrinolytic agent, in a dosage of 100 mg/kg every four hours for five days, up to a maximum daily dose of 30 g. Twenty patients (21 eyes with hyphema) received placebo in an identical regimen. One eye treated with aminocaproic acid rebled; seven eyes receiving the placebo rebled. The results of this study show a statistically significant reduction in the incidence of secondary hemorrhage in the patients receiving aminocaproic acid.
Original language | English (US) |
---|---|
Pages (from-to) | 1031-1033 |
Number of pages | 3 |
Journal | Archives of ophthalmology |
Volume | 101 |
Issue number | 7 |
DOIs | |
State | Published - Jul 1983 |
ASJC Scopus subject areas
- Ophthalmology